Investor buys 96 percent of Mölnlycke
Investor has reached an agreement with Morgan Stanley Principal Investments and certain of its affiliated entities to acquire their 34 percent equity stake in Mölnlycke Health Care Group for a total cash consideration of EUR 510 million.
Mölnlycke is a world leading manufacturer and provider of single-use surgical and wound care products and services, primarily for the professional healthcare sector. Investor together with MSPI initially invested in Mölnlycke early 2007.
Subsequent to the transaction Investor will own 96 percent and Mölnlycke's management and board will own the remaining shares. The offer implies an enterprise value of EUR 3.2 billion.
Read more
| Fund | Investor Growth Capital |
| Portfolio Company | Mölnlycke Health Care |
| Date of Transaction | 2010-08-26 |
| Transaction | Finance round |
| Seller | Morgan Stanley Principal Investments |
| Buyer | |
| Size of Transaction | EUR 510.0m |
| Ind. Focus | Life Science |
| Geography | Sweden |
| Stage | Small/mid-cap buyout |